Market Place
Sourcing Support
Delhi High Court seeks response from govt, NPPA on Glenmark`s plea
09 Apr 2024 //
ECONOMIC TIMES
Glenmark Pharma launches FDC drug for type 2 diabetes
26 Oct 2021 //
PHARMABIZ
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
29 Dec 2020 //
PRNEWSWIRE
Natco launches cut-price copies of AstraZeneca`s patented anti-diabetes drug
07 Apr 2020 //
ECONOMIC TIMES
Mankind Pharma signs up with Glenmark Pharmaceuticalsto co-market diabetes drug
23 Dec 2019 //
ECONOMIC TIMES
Glenmark gets approval to market combo remogliflozin etabonate & metformin HCl
19 Aug 2019 //
PHARMABIZ
Glenmark launches Remogliflozin combo in India; GeneCentric buys Select Immuno
19 Aug 2019 //
ENDPTS
Glenmark, Torrent Pharma sign agreement to co-market diabetes drug in India
17 Jul 2019 //
BUSINESS STANDARD
Glenmark and Torrent licensing deal for remogliflozin etabonate in India
11 Jul 2019 //
THE PHARMALETTER
Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India
30 Apr 2019 //
MONEYCONTROL
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.